Choice
Payments companies reported to CMS as associated with Choice. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Choice, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Choice
These are the largest totals companies reported as associated with Choice. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Azka Latif | Houston, TX | Internal Medicine | $22.40 |
| Fatima Lakhani | Saint Louis, MO | Internal Medicine | $22.39 |
| Anjula Chib | Dothan, AL | Cardiovascular Disease | $21.38 |
| Ashish Awasthi | Freehold, NJ | Cardiovascular Disease | $19.71 |
| Hassan Ashraf | Houston, TX | Internal Medicine | $18.54 |
| Syed Ali | Houston, TX | Interventional Cardiology | $18.54 |
| Timothy Mixon | Temple, TX | Interventional Cardiology | $16.20 |
| Patrick Zakka | West Hollywood, CA | Cardiovascular Disease | $5.02 |
| Abdolreza Agahtehrani | Louisville, KY | Interventional Cardiology | $4.10 |
Prescribed Choice?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.